$RFL News Article - Data on Rafael Pharmaceuticals' CPI-613 (devimistat) in Patients with Relapsed Burkitt Lymphoma to be Presented at the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition
https://marketwirenews.com/news-releases/data...26401.html